BerandaTWST • NASDAQ
add
Twist Bioscience Corp
$46,93
Setelah Jam Perdagangan Normal:(0,00%)0,00
$46,93
Tutup: 18 Okt, 16.25.35 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$45,52
Rentang hari
$45,19 - $46,99
Rentang tahun
$14,43 - $60,90
Kapitalisasi pasar
2,75 M USD
Volume Rata-Rata
714,80 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 81,46 jt | 27,81% |
Biaya operasional | 79,26 jt | 12,29% |
Laba bersih | -85,57 jt | -49,09% |
Margin laba bersih | -105,04 | -16,65% |
Penghasilan per saham | -0,70 | 31,23% |
EBITDA | -35,69 jt | 11,22% |
Tarif pajak efektif | -0,22% | — |
Neraca
Total aset
Total liabilitas
(USD) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 289,42 jt | -18,96% |
Total aset | 638,12 jt | -21,25% |
Total liabilitas | 146,98 jt | -3,80% |
Total ekuitas | 491,14 jt | — |
Saham yang beredar | 58,59 jt | — |
Harga terhadap nilai buku | 5,43 | — |
Tingkat pengembalian aset | -16,40% | — |
Tingkat pengembalian modal | -17,91% | — |
Arus Kas
Perubahan kas bersih
(USD) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | -85,57 jt | -49,09% |
Kas dari operasi | -6,38 jt | 72,76% |
Kas dari investasi | -711,00 rb | -103,81% |
Kas dari pembiayaan | 2,91 jt | 539,94% |
Perubahan kas bersih | -4,18 jt | 26,98% |
Arus kas bebas | 6,02 jt | 464,11% |
Tentang
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Didirikan
2013
Situs
Karyawan
919